Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Mitoxantrone Hydrochloride Liposome Combination Regimen in the Treatment of High-risk/Extramedullary Multiple Myeloma
ClinicalTrials.gov study NCT06246162. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06049290. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT03111992. IPD Sharing: NO. Countries: 4. Publications: 0.
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06433947. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT06407947. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine
ClinicalTrials.gov study NCT03762291. IPD Sharing: NO. Countries: 1. Publications: 0.
BCMA-CS1 Compound CAR (cCAR) T Cells for Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04156269. IPD Sharing: NO. Countries: 1. Publications: 0.
Comparison Between Whole Body DWI and FDG PET/CT in Patients with Simptomatic Multiple Myeloma
ClinicalTrials.gov study NCT06659276. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
CAR-T Cells Therapy in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03473496. IPD Sharing: NO. Countries: 1. Publications: 0.
MINIALO-VELCADE2005: A Study of Bortezomib (Velcade) Treated Multiple Myeloma Patients Pre and Post Allogeneic Haematopoietic Progenitor Cell Transplant With no Myeloablative Conditioning
ClinicalTrials.gov study NCT00564200. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT02605356. IPD Sharing: Not stated. Countries: 11. Publications: 0.
Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma.
ClinicalTrials.gov study NCT00532675. IPD Sharing: UNDECIDED. Countries: 4. Publications: 0.
COVID-19 Infection and Multiple Myeloma
ClinicalTrials.gov study NCT04492371. IPD Sharing: UNDECIDED. Countries: 8. Publications: 0.
Multiple Myeloma Prognostic Indices
ClinicalTrials.gov study NCT06095752. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02916420. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Plasma-free Replacement in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT05251896. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neurotoxic Effect of Bortezomib Treatment in Patient With Myeloma Multiple
ClinicalTrials.gov study NCT02976272. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.
ClinicalTrials.gov study NCT02909036. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunophenotyping of Plasma Cells and Immune Effector Cells in Peripheral Whole Blood and Bone Marrow Samples From Multiple Myeloma (MM) Patients
ClinicalTrials.gov study NCT05428163. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06465316. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.